- Home
- ICON vs NDRA Comparison
ICON vs NDRA Comparison
Compare ICON & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- NDRA
- Stock Information
- Founded
- ICON 2023
- NDRA 2007
- Country
- ICON Greece
- NDRA United States
- Employees
- ICON N/A
- NDRA N/A
- Industry
- ICON
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ICON
- NDRA Health Care
- Exchange
- ICON Nasdaq
- NDRA Nasdaq
- Market Cap
- ICON 3.6M
- NDRA 3.0M
- IPO Year
- ICON 2024
- NDRA 2017
- Fundamental
- Price
- ICON $0.22
- NDRA $4.65
- Analyst Decision
- ICON Strong Buy
- NDRA Strong Buy
- Analyst Count
- ICON 1
- NDRA 1
- Target Price
- ICON $7.00
- NDRA $14,000.00
- AVG Volume (30 Days)
- ICON 5.2M
- NDRA 10.9K
- Earning Date
- ICON 03-04-2025
- NDRA 03-27-2025
- Dividend Yield
- ICON 66.67%
- NDRA N/A
- EPS Growth
- ICON N/A
- NDRA N/A
- EPS
- ICON 0.30
- NDRA N/A
- Revenue
- ICON $4,810,000.00
- NDRA N/A
- Revenue This Year
- ICON $32.17
- NDRA N/A
- Revenue Next Year
- ICON $96.55
- NDRA N/A
- P/E Ratio
- ICON $0.82
- NDRA N/A
- Revenue Growth
- ICON 5.71
- NDRA N/A
- 52 Week Low
- ICON $0.19
- NDRA $4.01
- 52 Week High
- ICON $3.85
- NDRA $2,170.00
- Technical
- Relative Strength Index (RSI)
- ICON N/A
- NDRA 43.04
- Support Level
- ICON N/A
- NDRA $4.33
- Resistance Level
- ICON N/A
- NDRA $5.07
- Average True Range (ATR)
- ICON 0.00
- NDRA 0.33
- MACD
- ICON 0.00
- NDRA -0.01
- Stochastic Oscillator
- ICON 0.00
- NDRA 27.12
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.